Processa Pharmaceuticals (PCSA) Institutional Ownership → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free PCSA Stock Alerts $2.43 +0.81 (+50.00%) (As of 04:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Processa Pharmaceuticals (NASDAQ:PCSA)CurrentInstitutional OwnershipPercentage91.93%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$514.38KNumber ofInstitutional Sellers(last 12 months)0 Get PCSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Processa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PCSA Institutional Buying and Selling by Quarter Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Processa Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024Spinnaker Trust76,865$26K0.0%N/A6.249% 8/5/2022Coastal Bridge Advisors LLC52,500$148K0.0%+61.5%0.331% 2/15/2022Coastal Bridge Advisors LLC32,500$159K0.0%+18.2%0.207% 2/10/2022AIGH Capital Management LLC303,703$1.49M0.5%-21.5%1.932% 1/26/2022Verdence Capital Advisors LLC63,227$310K0.0%-14.3%0.402% 10/29/2021Janney Montgomery Scott LLC46,231$396K0.0%-18.5%0.296% 8/16/2021State Street Corp16,600$136K0.0%N/A0.107% 8/13/2021Geode Capital Management LLC37,400$306K0.0%+34.4%0.240% 8/13/2021Vanguard Group Inc.373,171$3.06M0.0%+136.7%2.397% 8/10/2021Coastal Bridge Advisors LLC27,500$225K0.0%+37.5%0.177% 8/9/2021Vectors Research Management LLC4,000$33K0.0%N/A0.026% 5/21/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/19/2021Worth Venture Partners LLC90,968$942K0.5%N/A0.586% 5/18/2021Millennium Management LLC93,999$1.03M0.0%-12.0%0.606% 5/18/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/17/2021Coastal Bridge Advisors LLC20,000$218K0.0%N/A0.129% 5/12/2021Northern Trust Corp12,845$140K0.0%N/A0.083% 5/12/2021Geode Capital Management LLC27,825$303K0.0%N/A0.179% 5/12/2021Essex Investment Management Co. LLC72,908$795K0.1%-2.7%0.470% 5/4/2021Commonwealth Equity Services LLC10,550$115K0.0%N/A0.068% 4/27/2021Janney Montgomery Scott LLC63,331$690K0.0%-4.5%0.408% 2/13/2021Essex Investment Management Co. LLC74,928$494K0.1%N/A0.709% (Data available from 1/1/2016 forward) PCSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PCSA shares? During the previous two years, the following institutional investors and hedge funds held shares of Processa Pharmaceuticals shares: Coastal Bridge Advisors LLC ($148K), Spinnaker Trust ($26K).Learn more on PCSA's institutional investors. What percentage of Processa Pharmaceuticals stock is owned by institutional investors? 91.93% of Processa Pharmaceuticals stock is owned by institutional investors. Learn more on PCSA's institutional investor holdings. Which institutional investors have been buying Processa Pharmaceuticals stock? The following institutional investors have purchased Processa Pharmaceuticals stock in the last 24 months: Spinnaker Trust ($76.87K), and Coastal Bridge Advisors LLC ($20K). How much institutional buying is happening at Processa Pharmaceuticals? Institutional investors have bought a total of 96,865 shares in the last 24 months. This purchase volume represents approximately $1.64M in transactions. Related Companies: Genprex Major Shareholders ZyVersa Therapeutics Major Shareholders Tharimmune Major Shareholders Lipella Pharmaceuticals Major Shareholders Kintara Therapeutics Major Shareholders Artelo Biosciences Major Shareholders Ensysce Biosciences Major Shareholders Virpax Pharmaceuticals Major Shareholders Cingulate Major Shareholders Kazia Therapeutics Major Shareholders This page (NASDAQ:PCSA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
